Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Solid Tumor 1Skin Neoplasms 1Myofibroma 1Leiomyoma 1Endometriosis 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Carcinoma, Ductal 1Bone Neoplasms 1Adenomyosis 1

Interventions

lenvatinib 3Magnetic Resonance Spectroscopy 3pembrolizumab 2gallium 68 PSMA-11 2Sorafenib 2Radiosurgery 2Cyclophosphamide 2Biopsy 268Ga-DKFZ-PSMA-11 2spartalizumab 1semaglutide 1peginterferon alfa-2b 1gadolinium ethoxybenzyl DTPA 1folfirinox 1fluoromisonidazole 1fludarabine 1atezolizumab 1alpha-2'-deoxythioguanosine 1Radiotherapy 1Propranolol 1Nivolumab 1Microscopy, Electron 1Indocyanine Green 1Ethiodized Oil 1Doxorubicin 1Cryosurgery 1CYT-6091 1Bevacizumab 1BO-112 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × Indocyanine Green × Clear all
NCT01962649 2018-04-25

A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green

Massachusetts General Hospital

Phase EARLY_PHASE1 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡